menu
    • menu

    Company profile for Secarna Pharma

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    In 2015, Secarna was founded by a team of highly experienced biotech professionals and investors. The company is located in Munich/Germany where we have established our discovery and development unit with more than 2.000 square feet of lab and office space at the IZB Martinsried, one of Germany`s most vibrant biotechnology clusters. Our operational set up, combined with Secarna`s talented staff and internationally accomplis...
    In 2015, Secarna was founded by a team of highly experienced biotech professionals and investors. The company is located in Munich/Germany where we have established our discovery and development unit with more than 2.000 square feet of lab and office space at the IZB Martinsried, one of Germany`s most vibrant biotechnology clusters. Our operational set up, combined with Secarna`s talented staff and internationally accomplished scientific advisors enable us to write new chapters in the book of antisense oligonucleotide discovery and development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Secarna PharmaGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Am Klopferspitz 19 82152 Planegg/Martinsried
    Telephone
    Telephone
    +49 6421/9830050
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.secarna.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Protalix Bio And Secarna Pharma Collaborate With Option Agreement
    Protalix Bio And Secarna Pharma Collaborate With Option Agreement

    17 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/protalix-biotherapeutics-and-secarna-pharmaceuticals-enter-into-collaboration-and-option-agreement-302644533.html

    PR NEWSWIRE
    17 Dec 2025
    Share Share
    Veraxa Biotech, Secarna Pharma Launch Immunology
    Veraxa Biotech, Secarna Pharma Launch Immunology

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158495/0/en/VERAXA-Biotech-and-Secarna-Pharmaceuticals-Initiate-Antibody-Oligonucleotide-Conjugate-Alliance-in-Immunology.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Secarna Pharmaceuticals to Present New Data for SECN-15 at ASCO
    Secarna Pharmaceuticals to Present New Data for SECN-15 at ASCO

    23 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/secarna-pharmaceuticals-to-present-new-data-and-clinical-strategy-for-1031176

    ACCESSWIRE
    23 May 2025
    Share Share
    Secarna to Present Showcasing the Innovation Potential of the LNAplus Platform
    Secarna to Present Showcasing the Innovation Potential of the LNAplus Platform

    17 Oct 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=793667&lang=en

    ACCESSWIRE
    17 Oct 2023
    Share Share
    Secarna Publishes Data In The Journal Of Immunology Demonstrating Potent Therapeutic Activity of LNAplus(TM) ASO
    Secarna Publishes Data In The Journal Of Immunology Demonstrating Potent Therapeutic Activity of LNAplus(TM) ASO

    06 Jul 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=765942&lang=en

    ACCESSWIRE
    06 Jul 2023
    Share Share
    Secarna and SciNeuro Enter into Agreement in the Field of CNS Diseases
    Secarna and SciNeuro Enter into Agreement in the Field of CNS Diseases

    27 Mar 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=745958&lang=en

    ACCESSWIRE
    27 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search